HEADER TRANSPORT PROTEIN 07-AUG-24 9J2N TITLE CRYO-EM STRUCTURE OF THE HUMAN GLUCOSE TRANSPORTER, GLUT7 IN OUTWARD- TITLE 2 FACING OPEN CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER COMPND 3 MEMBER 7; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: GLUCOSE TRANSPORTER TYPE 7,GLUT-7,HGLUT7; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC2A7, GLUT7; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS HUMAN GLUCOSE TRANSPORTER 7, SLC2A7, FRUCTOSE TRANSPORTER, INTESTINAL KEYWDS 2 HEXOSE ABSORPTION, MEMBRANE PROTEIN, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.S.LEE,S.KIM,M.S.JIN REVDAT 2 09-OCT-24 9J2N 1 JRNL REVDAT 1 25-SEP-24 9J2N 0 JRNL AUTH S.S.LEE,S.KIM,M.S.JIN JRNL TITL CRYO-EM STRUCTURE OF THE HUMAN GLUCOSE TRANSPORTER GLUT7. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 738 50544 2024 JRNL REFN ESSN 1090-2104 JRNL PMID 39163817 JRNL DOI 10.1016/J.BBRC.2024.150544 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.300 REMARK 3 NUMBER OF PARTICLES : 112978 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9J2N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-AUG-24. REMARK 100 THE DEPOSITION ID IS D_1300049765. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN GLUCOSE TRANSPORTER 7, REMARK 245 SLC2A7 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 4000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 20000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ASN A 3 REMARK 465 LYS A 4 REMARK 465 GLU A 5 REMARK 465 ALA A 6 REMARK 465 GLY A 7 REMARK 465 THR A 8 REMARK 465 PRO A 9 REMARK 465 PRO A 10 REMARK 465 PRO A 11 REMARK 465 ILE A 12 REMARK 465 PRO A 13 REMARK 465 SER A 14 REMARK 465 ARG A 15 REMARK 465 GLU A 16 REMARK 465 GLY A 17 REMARK 465 ARG A 486 REMARK 465 VAL A 487 REMARK 465 LYS A 488 REMARK 465 LEU A 489 REMARK 465 PRO A 490 REMARK 465 GLU A 491 REMARK 465 GLU A 492 REMARK 465 LYS A 493 REMARK 465 GLU A 494 REMARK 465 GLU A 495 REMARK 465 THR A 496 REMARK 465 ILE A 497 REMARK 465 ASP A 498 REMARK 465 ALA A 499 REMARK 465 GLY A 500 REMARK 465 PRO A 501 REMARK 465 PRO A 502 REMARK 465 THR A 503 REMARK 465 ALA A 504 REMARK 465 SER A 505 REMARK 465 PRO A 506 REMARK 465 ALA A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 THR A 510 REMARK 465 SER A 511 REMARK 465 PHE A 512 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 18 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 19 CG CD1 CD2 REMARK 470 GLN A 20 CG CD OE1 NE2 REMARK 470 LYS A 71 CG CD CE NZ REMARK 470 LYS A 129 CG CD CE NZ REMARK 470 GLU A 377 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 125 -37.04 -130.02 REMARK 500 HIS A 246 -107.56 -88.74 REMARK 500 THR A 247 -134.00 50.32 REMARK 500 VAL A 271 -58.79 63.91 REMARK 500 TYR A 322 -39.27 -38.13 REMARK 500 LEU A 435 -42.96 -143.91 REMARK 500 VAL A 465 -61.25 -102.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-61099 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF THE HUMAN GLUCOSE TRANSPORTER, GLUT7 IN REMARK 900 OUTWARD-FACING OPEN CONFORMATION DBREF 9J2N A 1 512 UNP Q6PXP3 GTR7_HUMAN 1 512 SEQRES 1 A 512 MET GLU ASN LYS GLU ALA GLY THR PRO PRO PRO ILE PRO SEQRES 2 A 512 SER ARG GLU GLY ARG LEU GLN PRO THR LEU LEU LEU ALA SEQRES 3 A 512 THR LEU SER ALA ALA PHE GLY SER ALA PHE GLN TYR GLY SEQRES 4 A 512 TYR ASN LEU SER VAL VAL ASN THR PRO HIS LYS VAL PHE SEQRES 5 A 512 LYS SER PHE TYR ASN GLU THR TYR PHE GLU ARG HIS ALA SEQRES 6 A 512 THR PHE MET ASP GLY LYS LEU MET LEU LEU LEU TRP SER SEQRES 7 A 512 CYS THR VAL SER MET PHE PRO LEU GLY GLY LEU LEU GLY SEQRES 8 A 512 SER LEU LEU VAL GLY LEU LEU VAL ASP SER CYS GLY ARG SEQRES 9 A 512 LYS GLY THR LEU LEU ILE ASN ASN ILE PHE ALA ILE ILE SEQRES 10 A 512 PRO ALA ILE LEU MET GLY VAL SER LYS VAL ALA LYS ALA SEQRES 11 A 512 PHE GLU LEU ILE VAL PHE SER ARG VAL VAL LEU GLY VAL SEQRES 12 A 512 CYS ALA GLY ILE SER TYR SER ALA LEU PRO MET TYR LEU SEQRES 13 A 512 GLY GLU LEU ALA PRO LYS ASN LEU ARG GLY MET VAL GLY SEQRES 14 A 512 THR MET THR GLU VAL PHE VAL ILE VAL GLY VAL PHE LEU SEQRES 15 A 512 ALA GLN ILE PHE SER LEU GLN ALA ILE LEU GLY ASN PRO SEQRES 16 A 512 ALA GLY TRP PRO VAL LEU LEU ALA LEU THR GLY VAL PRO SEQRES 17 A 512 ALA LEU LEU GLN LEU LEU THR LEU PRO PHE PHE PRO GLU SEQRES 18 A 512 SER PRO ARG TYR SER LEU ILE GLN LYS GLY ASP GLU ALA SEQRES 19 A 512 THR ALA ARG GLN ALA LEU ARG ARG LEU ARG GLY HIS THR SEQRES 20 A 512 ASP MET GLU ALA GLU LEU GLU ASP MET ARG ALA GLU ALA SEQRES 21 A 512 ARG ALA GLU ARG ALA GLU GLY HIS LEU SER VAL LEU HIS SEQRES 22 A 512 LEU CYS ALA LEU ARG SER LEU ARG TRP GLN LEU LEU SER SEQRES 23 A 512 ILE ILE VAL LEU MET ALA GLY GLN GLN LEU SER GLY ILE SEQRES 24 A 512 ASN ALA ILE ASN TYR TYR ALA ASP THR ILE TYR THR SER SEQRES 25 A 512 ALA GLY VAL GLU ALA ALA HIS SER GLN TYR VAL THR VAL SEQRES 26 A 512 GLY SER GLY VAL VAL ASN ILE VAL MET THR ILE THR SER SEQRES 27 A 512 ALA VAL LEU VAL GLU ARG LEU GLY ARG ARG HIS LEU LEU SEQRES 28 A 512 LEU ALA GLY TYR GLY ILE CYS GLY SER ALA CYS LEU VAL SEQRES 29 A 512 LEU THR VAL VAL LEU LEU PHE GLN ASN ARG VAL PRO GLU SEQRES 30 A 512 LEU SER TYR LEU GLY ILE ILE CYS VAL PHE ALA TYR ILE SEQRES 31 A 512 ALA GLY HIS SER ILE GLY PRO SER PRO VAL PRO SER VAL SEQRES 32 A 512 VAL ARG THR GLU ILE PHE LEU GLN SER SER ARG ARG ALA SEQRES 33 A 512 ALA PHE MET VAL ASP GLY ALA VAL HIS TRP LEU THR ASN SEQRES 34 A 512 PHE ILE ILE GLY PHE LEU PHE PRO SER ILE GLN GLU ALA SEQRES 35 A 512 ILE GLY ALA TYR SER PHE ILE ILE PHE ALA GLY ILE CYS SEQRES 36 A 512 LEU LEU THR ALA ILE TYR ILE TYR VAL VAL ILE PRO GLU SEQRES 37 A 512 THR LYS GLY LYS THR PHE VAL GLU ILE ASN ARG ILE PHE SEQRES 38 A 512 ALA LYS ARG ASN ARG VAL LYS LEU PRO GLU GLU LYS GLU SEQRES 39 A 512 GLU THR ILE ASP ALA GLY PRO PRO THR ALA SER PRO ALA SEQRES 40 A 512 LYS GLU THR SER PHE HET NAG A 601 15 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG C8 H15 N O6 HELIX 1 AA1 GLN A 20 SER A 43 1 24 HELIX 2 AA2 PRO A 48 ALA A 65 1 18 HELIX 3 AA3 ASP A 69 LEU A 93 1 25 HELIX 4 AA4 LEU A 94 ASN A 112 1 19 HELIX 5 AA5 ASN A 112 VAL A 124 1 13 HELIX 6 AA6 PHE A 131 ALA A 160 1 30 HELIX 7 AA7 PRO A 161 ASN A 163 5 3 HELIX 8 AA8 LEU A 164 SER A 187 1 24 HELIX 9 AA9 GLY A 197 LEU A 204 1 8 HELIX 10 AB1 GLY A 206 LEU A 216 1 11 HELIX 11 AB2 PRO A 217 PHE A 219 5 3 HELIX 12 AB3 SER A 222 GLN A 229 1 8 HELIX 13 AB4 ASP A 232 ARG A 244 1 13 HELIX 14 AB5 MET A 249 GLY A 267 1 19 HELIX 15 AB6 LEU A 277 SER A 279 5 3 HELIX 16 AB7 LEU A 280 LEU A 296 1 17 HELIX 17 AB8 GLY A 298 ALA A 313 1 16 HELIX 18 AB9 HIS A 319 GLY A 346 1 28 HELIX 19 AC1 GLY A 346 PHE A 371 1 26 HELIX 20 AC2 VAL A 375 GLU A 377 5 3 HELIX 21 AC3 LEU A 378 GLY A 396 1 19 HELIX 22 AC4 SER A 398 ILE A 408 1 11 HELIX 23 AC5 SER A 413 PHE A 434 1 22 HELIX 24 AC6 LEU A 435 GLY A 444 1 10 HELIX 25 AC7 TYR A 446 VAL A 465 1 20 HELIX 26 AC8 THR A 473 ASN A 485 1 13 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000